pyrazinamide has been researched along with nadp in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoki, N; Inoue, K; Sanada, H; Wada, O | 1 |
Inoue, B; Wachi, T | 1 |
Iwamoto, N; Sano, K; Shin, M; Umezawa, C; Yamashita, M | 1 |
Fukuwatari, T; Shibata, K; Sugimoto, E | 1 |
Chung, WJ; Jacobs, WR; Ngo, SC; Sayahi, H; Welch, JT; Zimhony, O | 1 |
Jacobs, WR; Sayahi, H; Shekhtman, A; Welch, JT; Zimhony, O | 1 |
Jacobs, WR; Pugliese, KM; Sayahi, H; Shekhtman, A; Welch, JT; Zimhony, O | 1 |
7 other study(ies) available for pyrazinamide and nadp
Article | Year |
---|---|
Effects of dietary pyrazinamide, tryptophan, or nicotinic acid and gamma-ray irradiation on levels of NAD and NADP in various organs of mice.
Topics: Animals; Eating; Female; Gamma Rays; Mice; Mice, Inbred C3H; NAD; NADP; Niacin; Organ Specificity; Pyrazinamide; Thymus Gland; Tryptophan | 1989 |
[Experimental study on the mechanism of development of fatty liver induced by antituberculous drugs--the effect of ethionamide on the NADPH-2 synthesizing enzymes].
Topics: Animals; Ethionamide; Fatty Acids; Fatty Liver; Glucosephosphate Dehydrogenase; Isocitrate Dehydrogenase; Liver; Malate Dehydrogenase; Male; NADP; Pyrazinamide; Rats | 1969 |
Pyridine nucleotide levels in liver of rats fed clofibrate- or pyrazinamide-containing diets.
Topics: Animals; Clofibrate; Diet; Female; Hypolipidemic Agents; Liver; Male; NAD; NADP; Pyrazinamide; Rats; Rats, Sprague-Dawley | 1998 |
Effects of dietary pyrazinamide, an antituberculosis agent, on the metabolism of tryptophan to niacin and of tryptophan to serotonin in rats.
Topics: Animals; Antitubercular Agents; Diet; Eating; Liver; Male; NAD; NADP; Niacin; Pyrazinamide; Quinolinic Acid; Rats; Rats, Wistar; Serotonin; Tryptophan; Weight Gain | 2001 |
Inhibition of isolated Mycobacterium tuberculosis fatty acid synthase I by pyrazinamide analogs.
Topics: Bacterial Proteins; Cell-Free System; Fatty Acid Synthases; Humans; Inhibitory Concentration 50; Kinetics; Mass Spectrometry; Molecular Structure; Mycobacterium tuberculosis; NADP; Oxidation-Reduction; Pyrazinamide; Reproducibility of Results; Substrate Specificity | 2007 |
Pyrazinamide, but not pyrazinoic acid, is a competitive inhibitor of NADPH binding to Mycobacterium tuberculosis fatty acid synthase I.
Topics: Bacterial Proteins; Binding Sites; Binding, Competitive; Crystallography, X-Ray; Enzyme Inhibitors; Fatty Acid Synthases; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; NADP; Pyrazinamide; Stereoisomerism; Structure-Activity Relationship | 2011 |
Analogs of the antituberculous agent pyrazinamide are competitive inhibitors of NADPH binding to M. tuberculosis fatty acid synthase I.
Topics: Antitubercular Agents; Bacterial Proteins; Fatty Acid Synthases; Humans; Mycobacterium tuberculosis; NADP; Protein Binding; Pyrazinamide; Tuberculosis | 2012 |